NCT04416178View on ClinicalTrials.gov

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

Active, not recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

March 26, 2024

Study Completion Date

December 31, 2025

Conditions

Sickle Cell Disease

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

St. Jude Children's Research Hospital

OTHER